Technote | Noggin (Qk034)
Qkine recombinant human noggin is as biologically active as a comparable alternative supplier protein
Noggin is a bone morphogenetic protein (BMP) antagonist which regulates cell differentiation and growth during embryonic development. Noggin is used in the culture of embryonic and pluripotent stem cells and to derive neural and microglial lineages. It can also be used to generate intestinal, pancreatic, lung, and tumor-derived organoids.
Qkine noggin (Qk034) is animal origin-free, carrier-free, tag-free, and non-glycosylated to ensure high and consistent bioactivity.
Qkine human noggin bioactivity
Qkine human noggin has a comparable bioactivity from an alternative major supplier. The bioactivity of Qkine noggin (Qk034, green) and Peprotech noggin (120-10C-20UG, Supplier B, black) was determined by inhibiting BMP-2 (Qk007) activity in a BMP-2 responsive HEK293T firefly luciferase reporter assay. Cells were treated in triplicate with a serial dilution of noggin and a standard concentration of BMP-2 for 6 hours. Protein concentrations were measured before use (Peprotech vial recovery 98%, Qkine 111%). Firefly luciferase activity was measured and normalized to control Renilla luciferase activity.
Qkine recombinant proteins are highly pure and animal origin-free, giving lot-to-lot consistency in bioactivity for long-term reproducible culture of stem cells and organoids.
Download PDFAll our recombinant proteins are animal-free and come with Bioactivity. Guaranteed.
About our products
Nine-point Quality Commitment
Qkine is committed to manufacturing bioactive proteins of the highest quality to enhance scientific outcomes and improve reproducibility.
Quality policy
Learn more about our quality management system implemented to comply with the requirements of ISO 9001: 2015.
Animal-free
Qkine manufactures recombinant proteins in a dedicated animal-free laboratory located in an ISO 9001: 2015 certified facility.
Contact us
Our science team is here to help, please contact us if you have any questions.